摘要
目的探讨宫腔镜子宫内膜息肉切除术（TCRP）联合炔诺酮治疗子宫内膜息肉（EP）的可行性和疗效.方法42例患者经宫腔镜检查诊断为子宫内膜息肉,均选择进行TCRP术,术后23例患者口服炔诺酮6～8片,每8 h一次,连续22d/月,共服3个月.所有病例均行病理检查并随访1年以上.结果42例中39例病理诊断为子宫内膜息肉,病理符合率为92.9%.TCRP联合药物组月经改善率为82.6%,复发率为13.0%;而单纯TCRP组月经改善率为75%,复发率为12.5%,两者比较差异无显著性.结论TCRP是治疗子宫内膜息肉的一种安全、有效的方法,术后使用妇康片可起预防性治疗的作用.
Objective To investigate the efficiency and feasibility of transcervical resection of polyp（TCRP） and Norethindrone for endometrial polyps（EP）. Methods 42 EP patients with hysteroscopy underwent TCRP,23 cases were given Norethindrone 6 - 8 tablets/8 hours, 22 days/ month for three months after TCRP. All cases were confirmed by pathology and were followed up for one year or more. Results The efficiency of all patients were noted one year after TCRP, 39 cases were accordant to pathology with the accurate diagnostic rate of 92.9%, Menstrual symptoms amelioration rate of the TCRP and Norethindrone group was 82.6%. The recurrence rate was 13%. While menstrual symptoms amelioration rate of the TCRP group was 75%. The recurrence rate was 12.5%. There were no significant defference between the two groups. Conclusion TCRP is a safe and effective treatment for EP. Using Norethindrone after TCRP have preventive function.
出处
《临床和实验医学杂志》
2006年第4期333-334,共2页
Journal of Clinical and Experimental Medicine
